Regulation of endobiotics glucuronidation by ligand-activated transcription factors: physiological function and therapeutic potential

References

• Abraham, N. G., Kappas, A. (2005). Heme oxygenase and the cardiovascular-renal system. Free Radic Biol Med 39:1–25.
   PubMed Web of Science ®Google Scholar
• Alme, B., Sjovall, J. (1980). Analysis of bile acid glucuronides in urine. Identification of 3 alpha, 6 alpha, 12 alpha-trihydroxy-5 beta-cholanoic acid. J Steroid Biochem 13:907–916.
   PubMedGoogle Scholar
• Back, P. (1976). Bile acid glucuronides, II[1]. Isolation and identification of a chenodeoxycholic acid glucuronide from human plasma in intrahepatic cholestasis. Hoppe Seylers Z Physiol Chem 357:213–217.
   PubMedGoogle Scholar
• Balk, S. P., Knudsen, K. E. (2008). AR, the cell cycle, and prostate cancer. Nucl Recept Signal 6:e001.
   PubMedGoogle Scholar
• Bao, B. Y., Chuang, B. F., Wang, Q., Sartor, O., Balk, S. P., Brown, M., et al. (2008). Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Prostate 68:839–848.
   PubMed Web of Science ®Google Scholar
• Barbier, O. (2008). Nuclear receptor-mediated regulation of phase II conjugating enzymes. In Xie, W. (Ed.), Nuclear receptors in drug metabolism. Wiley & Sons, Portland, OR.
   Google Scholar
• Barbier, O., Duran-Sandoval, D., Pineda-Torra, I., Kosykh, V., Fruchart, J. C., Staels, B. (2003a). Peroxisome proliferator-activated receptor alpha induces hepatic expression of the human bile acid glucuronidating UDP-glucuronosyltransferase 2B4 enzyme. J Biol Chem 278:32852–32860.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Fontaine, C., Fruchart, J. C., Staels, B. (2004). Genomic and nongenomic interactions of PPARalpha with xenobiotic-metabolizing enzymes. Trends Endocrinol Metab 15:324–330.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Torra, I. P., Sirvent, A., Claudel, T., Blanquart, C., Duran-Sandoval, D., et al. (2003b). FXR induces the UGT2B4 enzyme in hepatocytes: a potential mechanism of negative feedback control of FXR activity. Gastroenterology 124:1926–1940.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Trottier, J., Kaeding, J., Caron, P., Verreault, M. (2009). Lipid-activated transcription factors control bile acid glucuronidation. Mol Cell Biochem 326:3–8.
   PubMed Web of Science ®Google Scholar
• Barbier, O., Villeneuve, L., Bocher, V., Fontaine, C., Torra, I. P., Duhem, C., et al. (2003c). The UDP-glucuronosyltransferase 1A9 enzyme is a peroxisome proliferator-activated receptor alpha and gamma target gene. J Biol Chem 278:13975–13983.
   PubMed Web of Science ®Google Scholar
• Beaulieu, M., Lévesque, E., Tchernof, A., Beatty, B. G., Bélanger, A., Hum, D. W. (1997). Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid-metabolizing enzyme. DNA Cell Biol 16:1143–1154.
   PubMed Web of Science ®Google Scholar
• Bélanger, P., Paradis, D., Gagné, D., Bérubé, R., Bélanger, A. (2000). Determination of androsterone glucuronide and androstane-3alpha, 17beta-diol glucuronide in human plasma by turbo ionspray LC-MS/MS. 48th ASMS Conference on Mass Spectrometry and Allied Topics. Long Beach, California, USA June 11–15.
   Google Scholar
• Bélanger, A., Pelletier, G., Labrie, F., Barbier, O., Chouinard, S. (2003). Inactivation of androgens by UDP-glucuronosyltransferase enzymes in humans. Trends Endocrinol Metab 14:473–479.
   PubMed Web of Science ®Google Scholar
• Birnbaum, L. S., Tuomisto, J. (2000). Noncarcinogenic effects of TCDD in animals. Food Addit Contam 17:275–288.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Kohle, C. (2004). Coordinate regulation of drug metabolism by xenobiotic nuclear receptors: UGTs acting together with CYPs and glucuronide transporters. Drug Metab Rev 36:595–615.
   PubMed Web of Science ®Google Scholar
• Bock, K. W., Kohle, C. (2005). UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects. Meth Enzymol 400:57–75.
   PubMed Web of Science ®Google Scholar
• Bodin, K., Lindbom, U., Diczfalusy, U. (2005). Novel pathways of bile acid metabolism involving CYP3A4. Biochim Biophys Acta 1687:84–93.
   PubMed Web of Science ®Google Scholar
• Bonzo, J. A., Bélanger, A., Tukey, R. H. (2007). The role of chrysin and the Ah receptor in induction of the human UGT1A1 gene in vitro and in transgenic UGT1 mice. Hepatology 45:349–360.
   PubMed Web of Science ®Google Scholar
• Bosma, P. J. (2003). Inherited disorders of bilirubin metabolism. J Hepatol 38:107–117.
   PubMed Web of Science ®Google Scholar
• Breimer, L. H., Wannamethee, G., Ebrahim, S., Shaper, A. G. (1995). Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 41:1504–1508.
   PubMed Web of Science ®Google Scholar
• Buckley, D. B., Klaassen, C. D. (2009). Induction of mouse UDP-glucuronosyltransferase mRNA expression in liver and intestine by activators of aryl-hydrocarbon receptor, constitutive androstane receptor, pregnane X receptor, peroxisome proliferator-activated receptor alpha, and nuclear factor erythroid 2-related factor 2. Drug Metab Dispos 37:847–856.
   PubMed Web of Science ®Google Scholar
• Caron, P., Trottier, J., Verreault, M., Bélanger, J., Kaeding, J., Barbier, O. (2006). Enzymatic production of bile Acid glucuronides used as analytical standards for liquid chromatography–mass spectrometry analyses. Mol Pharm 3:293–302.
   PubMedGoogle Scholar
• Chen, S., Beaton, D., Nguyen, N., Senekeo-Effenberger, K., Brace-Sinnokrak, E., Argikar, U., et al. (2005). Tissue-specific, inducible, and hormonal control of the human UDP-glucuronosyltransferase-1 (UGT1) locus. J Biol Chem 280:37547–37557.
   PubMed Web of Science ®Google Scholar
• Chiang, J. Y. (2002) Bile Acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev, 23, 443–463.
   PubMed Web of Science ®Google Scholar
• Chouinard, S., Barbier, O., Bélanger, A. (2007). UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells. J Biol Chem 282:33466–33474.
   PubMed Web of Science ®Google Scholar
• Chouinard, S., Pelletier, G., Bélanger, A., Barbier, O. (2006). Isoform-specific regulation of uridine diphosphate-glucuronosyltransferase 2B enzymes in the human prostate: differential consequences for androgen and bioactive lipid inactivation. Endocrinology 147:5431–5442.
   PubMed Web of Science ®Google Scholar
• Chouinard, S., Yueh, M. F., Tukey, R. H., Giton, F., Fiet, J., Pelletier, G., et al. (2008). Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling. J Steroid Biochem Mol Biol 109:247–253.
   PubMed Web of Science ®Google Scholar
• Cunha, G. R., Ricke, W., Thomson, A., Marker, P. C., Risbridger, G., Hayward, S. W., et al. (2004). Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 92:221–236.
   PubMed Web of Science ®Google Scholar
• DePrimo, S. E., Diehn, M., Nelson, J. B., Reiter, R. E., Matese, J., Fero, M., et al. (2002). Transcriptional programs activated by exposure of human prostate cancer cells to androgen. Genome Biol 3:320–332.
   Google Scholar
• Djousse, L., Levy, D., Cupples, L. A., Evans, J. C., D’Agostino, R. B., Ellison, R. C. (2001). Total serum bilirubin and risk of cardiovascular disease in the Framingham Offspring Study. Am J Cardiol 87:1196–1200.
   PubMed Web of Science ®Google Scholar
• Dudnik, L. B., Khrapova, N. G. (1998). Characterization of bilirubin inhibitory properties in free radical oxidation reactions. Membr Cell Biol 12:233–240.
   PubMedGoogle Scholar
• Eloranta, J. J., Kullak-Ublick, G. A. (2005). Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 433:397–412.
   PubMed Web of Science ®Google Scholar
• Emi, Y., Ikushiro, S., Kato, Y. (2007). Thyroxine-metabolizing rat uridine diphosphate-glucuronosyltransferase 1A7 is regulated by thyroid hormone receptor. Endocrinology 148:6124–6133.
   PubMed Web of Science ®Google Scholar
• Gall, W. E., Zawada, G., Mojarrabi, B., Tephly, T. R., Green, M. D., Coffman, B. L., et al. (1999). Differential glucuronidation of bile acids, androgens, and estrogens by human UGT1A3 and 2B7. J Steroid Biochem Mol Biol 70:101–108.
   PubMed Web of Science ®Google Scholar
• Gardner-Stephen, D., Heydel, J. M., Goyal, A., Lu, Y., Xie, W., Lindblom, T., et al. (2004). Human PXR variants and their differential effects on the regulation of human UDP-glucuronosyltransferase gene expression. Drug Metab Dispos 32:340–347.
   PubMed Web of Science ®Google Scholar
• Girard, H., Lévesque, E., Bellemare, J., Journault, K., Caillier, B., Guillemette, C. (2007). Genetic diversity at the UGT1 locus is amplified by a novel 3’ alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genom 17:1077–1089.
   PubMed Web of Science ®Google Scholar
• Glass, C. K. (1994). Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev 15:391–407.
   PubMed Web of Science ®Google Scholar
• Gong, H., Singh, S. V., Singh, S. P., Mu, Y., Lee, J. H., Saini, S. P., et al. (2006). Orphan nuclear receptor pregnane X receptor sensitizes oxidative stress responses in transgenic mice and cancerous cells. Mol Endocrinol 20:279–290.
   PubMed Web of Science ®Google Scholar
• Gu, Y. Z., Hogenesch, J. B., Bradfield, C. A. (2000). The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 40:519–561.
   PubMed Web of Science ®Google Scholar
• Guillemette, C., Lévesque, E., Beaulieu, M., Turgeon, D., Hum, D. W., Belanger, A. (1997). Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology 138:2998–3005.
   PubMed Web of Science ®Google Scholar
• Hankinson, O. (1995). The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307–340.
   PubMed Web of Science ®Google Scholar
• Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R. et al. (2003). Induction of bilirubin clearance by the constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A 100:4156–4161.
   PubMed Web of Science ®Google Scholar
• Hunt, S. C., Kronenberg, F., Eckfeldt, J. H., Hopkins, P. N., Myers, R. H., Heiss, G. (2001). Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI Family Heart Study. Atherosclerosis 154:747–754.
   PubMed Web of Science ®Google Scholar
• Ikegawa, S., Okuyama, H., Oohashi, J., Murao, N., Goto, J. (1999). Separation and detection of bile acid 24-glucuronides in human urine by liquid chromatography combined electrospray ionization mass spectormetry. Anal Sci, 15, 625–631.
   Web of Science ®Google Scholar
• Jansen, P. L. (1999) Diagnosis and management of Crigler-Najjar syndrome. Eur J Pediatr, 158 Suppl 2, S89–S94.
   Google Scholar
• Kanda, T., Yokosuka, O., Imazeki, F., Saisho, H. (2003). Bezafibrate treatment: a new medical approach for PBC patients? J Gastroenterol 38:573–578.
   PubMed Web of Science ®Google Scholar
• Kapitulnik, J., Gonzalez, F. J. (1993). Marked endogenous activation of the CYP1A1 and CYP1A2 genes in the congenitally jaundiced Gunn rat. Mol Pharmacol 43:722–725.
   PubMed Web of Science ®Google Scholar
• Kazlauskas, A., Poellinger, L., Pongratz, I. (2000). The immunophilin-like protein, XAP2, regulates ubiquitination and subcellular localization of the dioxin receptor. J Biol Chem 275:41317–41724.
   PubMed Web of Science ®Google Scholar
• Kliewer, S. A., Willson, T. M. (2002). Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 43:359–364.
   PubMed Web of Science ®Google Scholar
• Kretschmer, X. C., Baldwin, W. S. (2005). CAR and PXR: xenosensors of endocrine disrupters? Chem Biol Interact 155:111–128.
   PubMed Web of Science ®Google Scholar
• Kronenberg, F., Coon, H., Gutin, A., Abkevich, V., Samuels, M. E., Ballinger, D. G., et al. (2002). A genome scan for loci influencing antiatherogenic serum bilirubin levels. Eur J Hum Genet 10:539–546.
   PubMed Web of Science ®Google Scholar
• Kronke, G., Kadl, A., Ikonomu, E., Bluml, S., Furnkranz, A., Sarembock, I. J., et al. (2007). Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors. Arterioscler Thromb Vasc Biol 27:1276–1282.
   PubMed Web of Science ®Google Scholar
• Kurihara, T., Maeda, A., Shigemoto, M., Yamashita, K., Hashimoto, E. (2002). Investigation into the efficacy of bezafibrate against primary biliary cirrhosis, with histological references from cases receiving long term monotherapy. Am J Gastroenterol 97:212–214.
   PubMed Web of Science ®Google Scholar
• Kurihara, T., Niimi, A., Maeda, A., Shigemoto, M., Yamashita, K. (2000). Bezafibrate in the treatment of primary biliary cirrhosis: comparison with ursodeoxycholic acid. Am J Gastroenterol 95:2990–2992.
   PubMed Web of Science ®Google Scholar
• Lamba, J. K., Lamba, V., Yasuda, K., Lin, Y. S., Assem, M., Thompson, E., et al. (2004). Expression of constitutive androstane receptor splice variants in human tissues and their functional consequences. J Pharmacol Exp Ther 311:811–821.
   PubMed Web of Science ®Google Scholar
• Lehmann, J. M., Mckee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., Kliewer, S. A. (1998). The human orphan nuclear receptor, PXR, is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest 102:1016–1023.
   PubMed Web of Science ®Google Scholar
• Lévesque, E., Beaulieu, M., Guillemette, C., Hum, D. W., Bélanger, A. (1998a). Effect of fibroblastic growth factors (FGF) on steroid UDP-glucuronosyltransferase expression and activity in the LNCaP cell line. J Steroid Biochem Mol Biol 64:43–48.
   PubMed Web of Science ®Google Scholar
• Lévesque, E., Beaulieu, M., Guillemette, C., Hum, D. W., Bélanger, A. (1998b). Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line. Endocrinology 139:2375–2381.
   PubMed Web of Science ®Google Scholar
• Li, Y. Q., Prentice, D. A., Howard, M. L., Mashford, M. L., Desmond, P. V. (2000). Bilirubin and bile acids may modulate their own metabolism via regulating uridine diphosphate-glucuronosyltransferase expression in the rat. J Gastroenterol Hepatol 15:865–870.
   PubMed Web of Science ®Google Scholar
• Lu, Y., Heydel, J. M., Li, X., Bratton, S., Lindblom, T., Radominska-Pandya, A. (2005). Lithocholic acid decreases expression of UGT2B7 in Caco-2 cells: a potential role for a negative farnesoid X receptor response element. Drug Metab Dispos 33:937–946.
   PubMed Web of Science ®Google Scholar
• Maines, M. D., Panahian, N. (2001). The heme oxygenase system and cellular defense mechanisms. Do HO-1 and HO-2 have different functions? Adv Exp Med Biol 502:249–272.
   PubMed Web of Science ®Google Scholar
• Mangelsdorf, D. J., Evans, R. M. (1995). The RXR heterodimers and orphan receptors. Cell 83:841–850.
   PubMed Web of Science ®Google Scholar
• Marschall, H. U., Matern, H., Wietholtz, H., Egestad, B., Matern, S., Sjovall, J. (1992). Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans. J Clin Invest 89:1981–1987.
   PubMed Web of Science ®Google Scholar
• Meng, L. J., Reyes, H., Palma, J., Hernandez, I., Ribalta, J., Sjovall, J. (1997). Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy. J Hepatol 27:346–357.
   PubMed Web of Science ®Google Scholar
• Moore, J. T., Collins, J. L., Pearce, K. H. (2006). The nuclear receptor superfamily and drug discovery. ChemMedChem 1:504–523.
   PubMed Web of Science ®Google Scholar
• Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., et al. (2000). Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 275:15122–15127.
   PubMed Web of Science ®Google Scholar
• Nakai, S., Masaki, T., Kurokohchi, K., Deguchi, A., Nishioka, M. (2000). Combination therapy of bezafibrate and ursodeoxycholic acid in primary biliary cirrhosis: a preliminary study. Am J Gastroenterol 95:326–327.
   PubMed Web of Science ®Google Scholar
• Nakata, K., Tanaka, Y., Nakano, T., Adachi, T., Tanaka, H., Kaminuma, T., et al. (2006). Nuclear receptor-mediated transcriptional regulation in phase I, II, and III xenobiotic metabolizing systems. Drug Metab Pharmacokinet 21:437–457.
   PubMed Web of Science ®Google Scholar
• Nebert, D. W., Roe, A. L., Dieter, M. Z., Solis, W. A., Yang, Y., Dalton, T. P. (2000). Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis. Biochem Pharmacol 59:65–85.
   PubMed Web of Science ®Google Scholar
• Nelson, P. S., Clegg, N., Arnold, H., Ferguson, C., Bonham, M., White, J., et al. (2002). The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci U S A 99:11890–11905.
   PubMed Web of Science ®Google Scholar
• Novotny, L., Vitek, L. (2003). Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood) 228:568–571.
   PubMed Web of Science ®Google Scholar
• Ohmoto, K., Mitsui, Y., Yamamoto, S. (2001). Effect of bezafibrate in primary biliary cirrhosis: a pilot study. Liver 21:223–224.
   PubMedGoogle Scholar
• Olinga, P., Elferink, M. G., Draaisma, A. L., Merema, M. T., Castell, J. V., Perez, G., et al. (2008). Coordinated induction of drug transporters and phase I and II metabolism in human liver slices. Eur J Pharm Sci 33:380–389.
   PubMed Web of Science ®Google Scholar
• Pascussi, J. M., Gerbal-Chaloin, S., Duret, C., Daujat-Chavanieu, M., Vilarem, M. J., Maurel, P. (2007). The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu Rev Pharmacol Toxicol 48:1–32.
   Web of Science ®Google Scholar
• Pauli-Magnus, C., Meier, P. J. (2005). Hepatocellular transporters and cholestasis. J Clin Gastroenterol 39:S103–S110.
   Google Scholar
• Peterson, S. J., Frishman, W. H. (2009). Targeting heme oxygenase: therapeutic implications for diseases of the cardiovascular system. Cardiol Rev 17:99–111.
   Google Scholar
• Phelan, D., Winter, G. M., Rogers, W. J., Lam, J. C., Denison, M. S. (1998). Activation of the Ah receptor signal transduction pathway by bilirubin and biliverdin. Arch Biochem Biophys 357:155–163.
   PubMed Web of Science ®Google Scholar
• Pillot, T., Ouzzine, M., Fournel-Gigleux, S., Lafaurie, C., Radominska, A., Burchell, B., et al. (1993). Glucuronidation of hyodeoxycholic acid in human liver. Evidence for a selective role of UDP-glucuronosyltransferase 2B4. J Biol Chem 268:25636–25642.
   PubMed Web of Science ®Google Scholar
• Russell, D. W., Setchell, K. D. (1992). Bile acid biosynthesis. Biochemistry 31:4737–4749.
   PubMed Web of Science ®Google Scholar
• Saini, S. P., Mu, Y., Gong, H., Toma, D., Uppal, H., Ren, S., et al. (2005). Dual role of orphan nuclear receptor pregnane X receptor in bilirubin detoxification in mice. Hepatology 41:497–505.
   PubMed Web of Science ®Google Scholar
• Schwertner, H. A. (2003). Bilirubin concentration, UGT1A1*28 polymorphism, and coronary artery disease. Clin Chem 49:1039–1040.
   PubMed Web of Science ®Google Scholar
• Schwertner, H. A., Jackson, W. G., Tolan, G. (1994). Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem 40:18–23.
   PubMed Web of Science ®Google Scholar
• Senekeo-Effenberger, K., Chen, S., Brace-Sinnokrak, E., Bonzo, J. A., Yueh, M. F., Argikar, U., et al. (2007). Expression of the human UGT1 locus in transgenic mice by 4-chloro-6-(2,3-xylidino)-2-pyrimidinylthioacetic acid (WY-14643) and implications on drug metabolism through peroxisome proliferator-activated receptor alpha activation. Drug Metab Dispos 35:419–427.
   PubMed Web of Science ®Google Scholar
• Seppen, J., Bosma, P. J., Goldhoorn, B. G., Bakker, C. T., Chowdhury, J. R., Chowdhury, N. R., et al. (1994). Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase. J Clin Invest 94:2385–2391.
   PubMed Web of Science ®Google Scholar
• Shaneyfelt, T., Husein, R., Bubley, G., Mantzoros, C. S. (2000). Hormonal predictores of prostate cancer: a meta-analysis. J Clin Oncol 18:847–853.
   PubMed Web of Science ®Google Scholar
• Sokol, R. J., Devereaux, M., Dahl, R., Gumpricht, E. (2006). “Let there be bile”—understanding hepatic injury in cholestasis. J Pediatr Gastroenterol Nutr 43(Suppl 1):S4–S9.
   PubMedGoogle Scholar
• Stanley, L. A., Horsburgh, B. C., Ross, J., Scheer, N., Wolf, C. R. (2006). PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity. Drug Metab Rev 38:515–597.
   PubMed Web of Science ®Google Scholar
• Starlard-Davenport, A., Lyn-Cook, B., Radominska-Pandya, A. (2008). Novel identification of UDP-glucuronosyltransferase 1A10 as an estrogen-regulated target gene. Steroids 73:139–147.
   PubMed Web of Science ®Google Scholar
• Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., Mackenzie, K. I., Latour, A., et al. (2001). The nuclear receptor, PXR, is a lithocholic acid sensor that protects against liver toxicity. Proc Natl Acad Sci U S A 98:3369–3374.
   PubMed Web of Science ®Google Scholar
• Stocker, R., Yamamoto, Y., McDonagh, A. F., Glazer, A. N., Ames, B. N. (1987). Bilirubin is an antioxidant of possible physiological importance. Science 235:1043–1046.
   PubMed Web of Science ®Google Scholar
• Sturm, E., Wagner, M., Trauner, M. (2009). Nuclear receptor ligands in therapy of cholestatic liver disease. Front Biosci 14:4299–4325.
   Web of Science ®Google Scholar
• Sueyoshi, T., Negishi, M. (2001). Phenobarbital response elements of cytochrome P450 genes and nuclear receptors. Annu Rev Pharmacol Toxicol 41:123–143.
   PubMed Web of Science ®Google Scholar
• Takikawa, H., Beppu, T., Seyama, Y., Obinata, K., Nittono, H. (1985). Serum concentrations of glucuronidated and sulfated bile acids in children with cholestasis. Biochem Med 33:381–386.
   PubMedGoogle Scholar
• Takikawa, H., Otsuka, H., Beppu, T., Seyama, Y., Yamakawa, T. (1983). Serum concentrations of bile acid glucuronides in hepatobiliary diseases. Digestion 27:189–195.
   PubMed Web of Science ®Google Scholar
• Temme, E. H., Zhang, J., Schouten, E. G., Kesteloot, H. (2001). Serum bilirubin and 10-year mortality risk in a Belgian population. Cancer Causes Contr 12:887–894.
   PubMed Web of Science ®Google Scholar
• Timsit, Y. E., Negishi, M. (2007). CAR and PXR: the xenobiotic-sensing receptors. Steroids 72:231–246.
   PubMed Web of Science ®Google Scholar
• Togawa, H., Shinkai, S., Mizutani, T. (2008). Induction of human UGT1A1 by bilirubin through AhR dependent pathway. Drug Metab Lett 2:231–237.
   PubMedGoogle Scholar
• Trottier, J., Milkiewicz, P., Kaeding, J., Verreault, M., Barbier, O. (2006a). Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Mol Pharm 3:212–222.
   PubMedGoogle Scholar
• Trottier, J., Verreault, M., Grepper, S., Monté, D., Bélanger, J., Kaeding, J., Caron, P., Inaba, T., Barbier, O. (2006b) Human UDP-glucuronosyltransferase (UGT)1A3 enzyme conjugates chenodeoxycholic in the liver. Hepatology, 44, 1158–1170.
   PubMed Web of Science ®Google Scholar
• Turgeon, D., Carrier, J. S., Levesque, E., Beatty, B. G., Bélanger, A., Hum, D. W. (2000) Isolation and characterization of the human UGT2B15 gene, localized within a cluster of UGT2B genes and pseudogenes on chromosome 4. J Mol Biol 295:489–504.
   PubMed Web of Science ®Google Scholar
• Turgeon, D., Carrier, J. S., Lévesque, é., Hum, D. W., Bélanger, A. (2001). Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members. Endocrinology 142:778–787.
   PubMed Web of Science ®Google Scholar
• Tzameli, I., Moore, D. D. (2001). Role reversal: new insights from new ligands for the xenobiotic receptor CAR. Trends Endocrinol Metab 12:7–10.
   PubMed Web of Science ®Google Scholar
• Vierling, J. M. (2005). Future treatment options in PBC. Semin Liver Dis 25:347–363.
   PubMed Web of Science ®Google Scholar
• Vitek, L., Jirsa, M., Brodanova, M., Kalab, M., Marecek, Z., Danzig, V., et al. (2002). Gilbert’s syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 160:449–456.
   PubMed Web of Science ®Google Scholar
• Vyhlidal, C. A., Rogan, P. K., Leeder, J. S. (2004). Development and refinement of pregnane X receptor (PXR) DNA binding site model using information theory: insights into PXR-mediated gene regulation. J Biol Chem 279:46779–46786.
   PubMed Web of Science ®Google Scholar
• Wei, M., Schwertner, H. A., Zeng, Q., Blair, S. N. (2000). Fasting serum bilirubin concentrations and the risk of subsequent coronary heart disease death in men. Hepatology 32:314A.
   Web of Science ®Google Scholar
• Westerink, W. M., Schoonen, W. G. (2007). Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells. Toxicol In Vitro 21:1592–1602.
   PubMed Web of Science ®Google Scholar
• Wietholtz, H., Marschall, H. U., Sjovall, J., Matern, S. (1996). Stimulation of bile acid 6 alpha-hydroxylation by rifampin. J Hepatol 24:713–718.
   PubMed Web of Science ®Google Scholar
• Xie, W., Yeuh, M. F., Radominska-Pandya, A., Saini, S. P., Negishi, Y., Bottroff, B. S., et al. (2003). Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor. Proc Natl Acad Sci U S A 100:4150–4155.
   PubMed Web of Science ®Google Scholar
• Yano, K., Kato, H., Morita, S., Takahara, O., Ishibashi, H., Furukawa, R. (2002). Is bezafibrate histologically effective for primary biliary cirrhosis? Am J Gastroenterol 97:1075–1077.
   PubMed Web of Science ®Google Scholar
• Yueh, M. F., Huang, Y. H., Hiller, A., Chen, S., Nguyen, N., Tukey, R. H. (2003). Involvement of the xenobiotic response element (XRE) in Ah receptor-mediated induction of human UDP-glucuronosyltransferase 1A1. J Biol Chem 278:15001–15006.
   PubMed Web of Science ®Google Scholar
• Zhou, J., Zhang, J., Xie, W. (2005). Xenobiotic nuclear receptor-mediated regulation of UDP-glucuronosyl-transferases. Curr Drug Metab 6:289–298.
   PubMed Web of Science ®Google Scholar
• Zhou, Z., Lane, M., Kemppainen, J., French, F., Wilson, E. (1995). Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. Mol Endocrinol 9:208–218.
   PubMed Web of Science ®Google Scholar
• Zimniak, P., Holsztynska, E. J., Lester, R., Waxman, D. J., Radominska, A. (1989). Detoxification of lithocholic acid. Elucidation of the pathways of oxidative metabolism in rat liver microsomes. J Lipid Res 30:907–918.
   PubMed Web of Science ®Google Scholar